Literature DB >> 22574830

Transmission of clear cell tumor in a graft liver from cadaveric donor: case report.

Ariane N Backes1, Ana Cristina A Tannuri, Evandro Sobroza de Mello, Nelson Elias M Gibelli, Wagner de Castro Andrade, Uenis Tannuri.   

Abstract

Neoplasms in children after organ transplantation are related to the type and intensity of immunosuppression and the donor-recipient serostatus, especially in relation to the Epstein-Barr virus. The patient was a two-yr-old female child with biliary atresia who underwent a liver transplantation from a female cadaver donor. Two adults received kidney transplants from the same donor. Nine months after transplantation, one of the adult recipients developed an urothelial tumor in the kidney graft. Imaging tests were repeated monthly in the liver-transplanted child and revealed no abnormalities. However, one yr and two months after the transplantation, the patient developed episodes of fever. At that time, imaging and liver biopsy showed a clear cell tumor of urothelial origin in the graft and the disease was limited to the liver. The patient underwent liver retransplantation, and she is currently free of tumor recurrence. Although rare, the occurrence of tumors in the post-transplant period from cadaver donors, without previously diagnosed tumors, is one of the many problems encountered in the complex world of organ transplantation.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574830     DOI: 10.1111/j.1399-3046.2012.01711.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

Review 1.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

2.  Donor-Transmitted Cancer in Orthotopic Solid Organ Transplant Recipients: A Systematic Review.

Authors:  George H B Greenhall; Maria Ibrahim; Utkarsh Dutta; Carolyn Doree; Susan J Brunskill; Rachel J Johnson; Laurie A Tomlinson; Chris J Callaghan; Christopher J E Watson
Journal:  Transpl Int       Date:  2022-02-04       Impact factor: 3.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.